Omada Health, Inc.
For the period ended Mar 5, 2026. Filed Mar 5, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Mar 5, 2026 · Filed Mar 5, 2026
Contents
EX-99.1 · Program Innovation
Program Innovation
During 2025, launched OmadaSpark and Meal Map, AI-powered tools that support members with wellness education alongside our human coaches
In February of 2026, announced Omada for Cholesterol to address a highly prevalent, often under‑treated condition that frequently co‑exists with diabetes, hypertension, and
obesity, further strengthening its multi‑condition platform capabilities and expanding the scope of Omada’s cardiometabolic care
“Our 2025 performance reflects a pivotal year for Omada, marked by strong growth, important profitability milestones, and continued momentum across our business,” said Sean Duffy, co‑founder and CEO of Omada Health. “We demonstrated GLP‑1 companion support innovation, advanced our member‑facing AI capabilities, and introduced meaningful program expansions—all designed to support our members in achieving durable health improvements and serving as a foundation for progress toward our long‑term mission to bend the curve of chronic disease.”
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.